Great Point Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-53,632
Closed -$405K 32
2018
Q2
$405K Buy
+53,632
New +$405K 0.06% 29